As the world prepares for another season of respiratory illness, we want to keep you updated on what vaccines are available and current recommendations.
Respiratory Syncytial Virus (RSV) Vaccination: RSV is a contagious respiratory illness that spreads in the fall and winter months. Most people get a mild illness from an RSV infection with cold-like symptoms. However, it can make older adults and young children very sick. The CDC recommends that people ages 75 and older (or people ages 50-74 with increased risk for lower respiratory tract disease) get the RSV vaccine after talking with their doctor to see if it’s right for them. The RSV vaccine is only one dose and is not currently an annual vaccine. Some pregnant women may also be eligible for the RSV vaccine with a valid prescription.
COVID-19 Vaccine: As the COVID-19 virus continues to mutate, on-going research aims to refine vaccine strategies to address new variants. The CDC recommends everyone six months and older to get one dose of the new 2024/2025 COVID-19 vaccine, regardless of COVID-19 vaccines received in the past. The 2024/2025 COVID-19 vaccine will protect against JN strains, which are variants of Omicron. This new vaccine is expected to be available in fall 2024. We do not currently have this vaccine in stock. Our ability to offer the vaccine will depend on availability and insurance coverage. We will update you on our website and social media once more information is known.
Influenza Vaccine: With the flu season approaching, the importance of influenza vaccinations cannot be overstated. Flu shots have long been a mainstay in preventive medicine, offering protection against seasonal influenza strains. High dose flu shots will be available this year again for people 65 years and older. These high dose vaccines can potentially provide stronger immunity in older adults with weaker immune responses. According to the CDC, all flu vaccines for 2024/2025 will be trivalent and will protect against H1N1, H3N2, and a B/Victoria lineage virus. As the medical community strives to keep up with evolving flu strains, these vaccine options ensure a tailored approach to flu prevention.
Pneumonia Vaccine: Pneumonia vaccines help prevent against pneumococcal disease; a respiratory illness caused by bacteria. There are two types of pneumonia vaccines available in the United States: pneumococcal conjugate vaccines (PCV15 and PCV20) and pneumococcal polysaccharide vaccines (PPSV23). Though they are composed differently, both types protect against numerous pneumococcal bacterial strains. The CDC currently recommends one dose of the newest vaccine, PCV20, for protection against pneumonia for anyone age 65 or older that has not previously been vaccinated. People under 65 and people who have already received a previous pneumonia vaccine may still be eligible for PCV20 and should call the pharmacy or their physician to discuss.
As new research emerges and vaccination guidelines evolve, we strive to be your reputable resource. By staying informed, you can make educated decisions for yourself and your loved ones, contributing to a healthier and safer community.
*These statements are culmination of the knowledge and experience of the team at Carl's Drug. The information provided here is for informational purposes only. Please consult your healthcare provider with questions concerning any medical condition or treatment. Compounded medications are not reviewed by the FDA for safety or efficacy. These statements have not been evaluated by the Food and Drug Administration, and this product is not intended to diagnose, treat, cure or prevent any disease.
Comments